Jinane Ghattas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jinane Ghattas has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Brecht Devleesschauwer
Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium; Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium
2 shared publications - Niko Speybroeck
Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium
2 shared publications - Ali Ghaddar
Department of Biomedical Science, Lebanese International University, Beirut 146404, Lebanon
1 shared publication Barbora Vasinova
1 shared publicationFelipe Ponce Bollmann
1 shared publication- James Cottam
Department of Pain and Translational Symptom Science, School of Nursing, University of Maryland, Baltimore, MD, United States
1 shared publication
Latest Publications
- Open Access
- 3 November 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-9
COVID-19 contact tracing at work in Belgium - how tracers tweak guidelines for the better
Background: When conducting COVID-19 contact tracing, pre-defined criteria allow differentiating high-risk contacts (HRC) from low-risk contacts (LRC). Our study aimed to evaluate whether contact tracers in Belgium followed these criteria in practice and whether their deviations improved the infection risk assessment.Method: We conducted a retrospective cohort study in Belgium, through an anonymous online survey, sent to 111,763 workers by email. First, we evaluated the concordance between the guideline-based classification of HRC or LRC and the tracer’s classification. We computed positive and negative agreements between both. Second, we used a multivariate Poisson regression to calculate the risk ratio (RR) of testing positive depending on the risk classification by the contact tracer and by the guideline-based risk classification.Results: For our first research question, we included 1105 participants. The positive agreement between the guideline-based classification in HRC or LRC and the tracer’s classification was 0.53 (95% CI 0.49–0.57) and the negative agreement 0.70 (95% CI: 0.67–0.72). The type of contact tracer (occupational doctors, internal tracer, general practitioner, other) did not significantly influence the results. For the second research question, we included 589 participants. The RR of testing positive after an HRC compared to an LRC was 3.10 (95% CI: 2.71–3.56) when classified by the contact tracer and 2.24 (95% CI: 1.94–2.60) when classified by the guideline-based criteria.Conclusion: Our study indicates that contact tracers did not apply pre-defined criteria for classifying high and low risk contacts. Risk stratification by contact tracers predicts who is at risk of infection better than guidelines only. This result indicates that a knowledgeable tracer can target testing better than a general guideline, asking for a debate on how to adapt the guidelines.
- 3 November 2023
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-9
Open AccessCOVID-19 contact tracing at work in Belgium - how tracers tweak guidelines for the better
Background: When conducting COVID-19 contact tracing, pre-defined criteria allow differentiating high-risk contacts (HRC) from low-risk contacts (LRC). Our study aimed to evaluate whether contact tracers in Belgium followed these criteria in practice and whether their deviations improved the infection risk assessment.Method: We conducted a retrospective cohort study in Belgium, through an anonymous online survey, sent to 111,763 workers by email. First, we evaluated the concordance between the guideline-based classification of HRC or LRC and the tracer’s classification. We computed positive and negative agreements between both. Second, we used a multivariate Poisson regression to calculate the risk ratio (RR) of testing positive depending on the risk classification by the contact tracer and by the guideline-based risk classification.Results: For our first research question, we included 1105 participants. The positive agreement between the guideline-based classification in HRC or LRC and the tracer’s classification was 0.53 (95% CI 0.49–0.57) and the negative agreement 0.70 (95% CI: 0.67–0.72). The type of contact tracer (occupational doctors, internal tracer, general practitioner, other) did not significantly influence the results. For the second research question, we included 589 participants. The RR of testing positive after an HRC compared to an LRC was 3.10 (95% CI: 2.71–3.56) when classified by the contact tracer and 2.24 (95% CI: 1.94–2.60) when classified by the guideline-based criteria.Conclusion: Our study indicates that contact tracers did not apply pre-defined criteria for classifying high and low risk contacts. Risk stratification by contact tracers predicts who is at risk of infection better than guidelines only. This result indicates that a knowledgeable tracer can target testing better than a general guideline, asking for a debate on how to adapt the guidelines.
- Open Access
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Etiological and prognostic roles of socioeconomic characteristics in the development of sars-cov-2 infection and related severe health outcomes: systematic review of population-based studies
Background and Objective: There is growing evidence on the role of biomedical factors and socioeconomic status in increasing vulnerability to COVID-19. We conducted a systematic review to investigate the etiological and prognostic roles of multimorbidity, frailty and socioeconomic determinants...
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessEtiological and prognostic roles of socioeconomic characteristics in the development of sars-cov-2 infection and related severe health outcomes: systematic review of population-based studies
Background and Objective: There is growing evidence on the role of biomedical factors and socioeconomic status in increasing vulnerability to COVID-19. We conducted a systematic review to investigate the etiological and prognostic roles of multimorbidity, frailty and socioeconomic determinants...
- Open Access
- 10 November 2021
- Published by Springer Nature in Research Square
The State of Health in Belgium, 1990–2019: A Benchmarking Analysis Based on the Global Burden of Disease 2019 Study
BackgroundIn spite of high health expenditures and several reforms, Belgian healthcare system shows unsatisfactory health outcomes. Evidence-based decision-making is essential in a context of decreasing resources and growing health needs. This study aims to assess the health trends in Belgium between 1990 and 2019, to compare the Belgian health status to that of the EU-15 countries, and to identify the main drivers in trends over time and country differences within the EU-15.MethodsWe extracted estimates from the GBD 2019 study via the GBD results tool and visualization tools. We compared the Belgian health status with 14 European Union comparator countries between 1990 and 2019. Results Life expectancy (LE) in Belgium improved significantly between 1900 and 2019 for both men and women. Belgium Age-standardised (AS) mortality dropped significantly for men (-40%) and women (-33%) between 1990 and 2019. Belgium performed significantly better in 2019 than in 1990 in terms of AS Year of Life Lost (YLL) rates. The main contributors to the significant premature mortality decrease were ischemic heart disease, lung cancer and road injuries in men; ischemic heart disease, stroke and breast cancer in women. AS Years lived with disability (YLD) did not significantly differ between 1990 and 2019. Overall, Belgium AS Disability-Adjusted Life Year (DALY) rates dropped by 23%. This decrease is mainly due to decreasing trend in YLL rates while YLDs rates remained stable. Compared to EU-15, Belgium ranking worsened in terms of AS DALY rates for both men and women in 2019. The main contributors for AS DALY rates were ischemic heart disease, lung cancer and self-harm in men; headache disorders, low back pain and gynaecological disorders in women.ConclusionNon-communicable diseases are the main contributors for health burden in Belgium since 1990. Despite the considerable improvement, Belgium’s ranking for DALYs decreased between 1990 and 2019 compared to the EU-15. Primary and secondary prevention could be crucial elements to improve patient health outcomes and reduce their burden on the healthcare system.
- 10 November 2021
- Published by Springer Nature in Research Square
Open AccessThe State of Health in Belgium, 1990–2019: A Benchmarking Analysis Based on the Global Burden of Disease 2019 Study
BackgroundIn spite of high health expenditures and several reforms, Belgian healthcare system shows unsatisfactory health outcomes. Evidence-based decision-making is essential in a context of decreasing resources and growing health needs. This study aims to assess the health trends in Belgium between 1990 and 2019, to compare the Belgian health status to that of the EU-15 countries, and to identify the main drivers in trends over time and country differences within the EU-15.MethodsWe extracted estimates from the GBD 2019 study via the GBD results tool and visualization tools. We compared the Belgian health status with 14 European Union comparator countries between 1990 and 2019. Results Life expectancy (LE) in Belgium improved significantly between 1900 and 2019 for both men and women. Belgium Age-standardised (AS) mortality dropped significantly for men (-40%) and women (-33%) between 1990 and 2019. Belgium performed significantly better in 2019 than in 1990 in terms of AS Year of Life Lost (YLL) rates. The main contributors to the significant premature mortality decrease were ischemic heart disease, lung cancer and road injuries in men; ischemic heart disease, stroke and breast cancer in women. AS Years lived with disability (YLD) did not significantly differ between 1990 and 2019. Overall, Belgium AS Disability-Adjusted Life Year (DALY) rates dropped by 23%. This decrease is mainly due to decreasing trend in YLL rates while YLDs rates remained stable. Compared to EU-15, Belgium ranking worsened in terms of AS DALY rates for both men and women in 2019. The main contributors for AS DALY rates were ischemic heart disease, lung cancer and self-harm in men; headache disorders, low back pain and gynaecological disorders in women.ConclusionNon-communicable diseases are the main contributors for health burden in Belgium since 1990. Despite the considerable improvement, Belgium’s ranking for DALYs decreased between 1990 and 2019 compared to the EU-15. Primary and secondary prevention could be crucial elements to improve patient health outcomes and reduce their burden on the healthcare system.
- Open Access
- 1 September 2020
- Published by Elsevier in Gaceta Sanitaria
- Vol. 34 (5) , 493-499
Justifying abuse of women migrant domestic workers in Lebanon: the opinion of recruitment agencies
- 1 September 2020
- Published by Elsevier in Gaceta Sanitaria
- Vol. 34 (5) , 493-499
Open AccessJustifying abuse of women migrant domestic workers in Lebanon: the opinion of recruitment agencies